Published online December 31, 2007
PEDIATRICS Vol. 121 No. 1 January 2008, pp. 223-224 (doi:10.1542/peds.2007-3069)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bocchini, J. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Bocchini, J. A., Jr
Related Collections
Right arrow Infectious Disease & Immunity

LETTER TO THE EDITOR

Efficacy of the Pentavalent Rotavirus Vaccine in Subjects After 1 or 2 Doses in the Rotavirus Efficacy and Safety Trial: In Reply

American Academy of Pediatrics Committee on Infectious Diseases
Joseph A. Bocchini, Jr, MD, Chairperson
The first 20% of the full text of this article appears below.

We thank Dr Bernstein for his letter regarding clarification of data discrepancies between the policy statement "Prevention of Rotavirus Disease: Guidelines . . . [Full Text of this Article]